Alfredo Iloreta, MD
Urology · Topeka, KSNPI 1790751576
Payments from drug & device makers
Across 67 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$461
- Pfizer$146
- Johnson & Johnson$137
- AbbVie$74
- Myriad Genetic Laboratories, Inc.$55
- Profound Medical Corp.$55
- plus $436 from 19 others
What the payments were for
- Food & beverage$1,27894%
- Education$856%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 20 | $461 |
| Pfizer | 8 | $146 |
| Johnson & Johnson | 5 | $137 |
| AbbVie(2 entities) | 5 | $74 |
| Myriad Genetic Laboratories, Inc. | 3 | $55 |
| Profound Medical Corp. | 1 | $55 |
| Blue Earth Diagnostics | 3 | $44 |
| Boston Scientific | 2 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Endo Pharmaceuticals Inc. | 2 | $31 |
| Teleflex LLC | 1 | $30 |
| Myovant Sciences Inc. | 2 | $25 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
| Medtronic | 1 | $23 |
| BD | 1 | $20 |
| Neotract Inc. | 1 | $20 |
| Ambu Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Tolmar Pharmaceuticals, Inc. | 1 | $17 |
| Cook Medical LLC | 1 | $16 |
| KARL Storz Endoscopy-america | 1 | $14 |
| Coloplast | 1 | $14 |
| Olympus America Inc. | 1 | $14 |
| Urogen Pharma, Inc. | 1 | $12 |
| Rochester Medical Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYRBETRIQ$110
How this compares
$1,364 in reported general payments places this provider in the 30th percentile of 111 urology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 399 | $4,549 |
| Finasteride | 371 | $3,897 |
| Silodosin | 18 | $1,280 |
| Dutasteride | 15 | $577 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $283 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 52 | $148 |
| Ciprofloxacin Hcl | 40 | $147 |
| Cephalexin | 47 | $113 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $105 |
| Allopurinol | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other urology in Topeka
- Loren SmithTopeka$4K
- Bradley RuppTopeka$3K
- Son NguyenMerriam$6.4M
- Timothy RichardsonWichita$5.3M
- Fadi JoudiWichita$2.3M
- Eugene LeeKansas City$2.2M
- Wilson MolinaKansas City$513K
- Jeffrey HolzbeierleinKansas City$341K
- Bristol WhilesKansas City$290K
- Philippe NabboutWichita$183K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.